Literature DB >> 15546399

The role of cytokine DNAs as vaccine adjuvants for optimizing cellular immune responses.

Dan H Barouch1, Norman L Letvin, Robert A Seder.   

Abstract

Cytokines represent a diverse group of immunologic effector and regulatory proteins that are critical components of the host response to invading pathogens. They have also been utilized as adjuvants to enhance immune responses to vaccines. In particular, plasmid cytokines have been studied extensively as candidate adjuvants for DNA vaccines in preclinical models and are now entering early-phase clinical trials. Here, we review recent advances in our understanding of cytokine biology, T-lymphocyte differentiation, and potential applications of plasmid cytokines in the rational design of improved vaccines.

Mesh:

Substances:

Year:  2004        PMID: 15546399     DOI: 10.1111/j.0105-2896.2004.00200.x

Source DB:  PubMed          Journal:  Immunol Rev        ISSN: 0105-2896            Impact factor:   12.988


  31 in total

1.  Dendritic cell targeted HIV gag protein vaccine provides help to a DNA vaccine including mobilization of protective CD8+ T cells.

Authors:  Godwin Nchinda; David Amadu; Christine Trumpfheller; Olga Mizenina; Klaus Uberla; Ralph M Steinman
Journal:  Proc Natl Acad Sci U S A       Date:  2010-02-16       Impact factor: 11.205

2.  Multimeric soluble CD40 ligand and GITR ligand as adjuvants for human immunodeficiency virus DNA vaccines.

Authors:  Geoffrey W Stone; Suzanne Barzee; Victoria Snarsky; Kristin Kee; Celsa A Spina; Xiao-Fang Yu; Richard S Kornbluth
Journal:  J Virol       Date:  2006-02       Impact factor: 5.103

3.  The efficacy of DNA vaccination is enhanced in mice by targeting the encoded protein to dendritic cells.

Authors:  Godwin Nchinda; Janelle Kuroiwa; Margarita Oks; Christine Trumpfheller; Chae Gyu Park; Yaoxing Huang; Drew Hannaman; Sarah J Schlesinger; Olga Mizenina; Michel C Nussenzweig; Klaus Uberla; Ralph M Steinman
Journal:  J Clin Invest       Date:  2008-04       Impact factor: 14.808

4.  Biomaterials at the interface of nano- and micro-scale vector-cellular interactions in genetic vaccine design.

Authors:  Charles H Jones; Anders P Hakansson; Blaine A Pfeifer
Journal:  J Mater Chem B       Date:  2014-09-12       Impact factor: 6.331

5.  A novel immunization strategy using cytokine/chemokines induces new effective systemic immune responses, and frequent complete regressions of human metastatic melanoma.

Authors:  Fred T Valentine; Frederick M Golomb; Matthew Harris; Daniel F Roses
Journal:  Oncoimmunology       Date:  2017-10-30       Impact factor: 8.110

6.  CD4+ T cell-independent DNA vaccination against opportunistic infections.

Authors:  Mingquan Zheng; Alistair J Ramsay; Myles B Robichaux; Corrine Kliment; Christopher Crowe; Rekha R Rapaka; Chad Steele; Florencia McAllister; Judd E Shellito; Luis Marrero; Paul Schwarzenberger; Qiu Zhong; Jay K Kolls
Journal:  J Clin Invest       Date:  2005-11-23       Impact factor: 14.808

7.  Evaluation of humoral and cellular immune responses to a DNA vaccine encoding chicken type II collagen for rheumatoid arthritis in normal rats.

Authors:  Zhao Xiao; Long Juan; Yun Song; Zhang Zhijian; Jin Jing; Yu Kun; Hao Yuna; Dai Dongfa; Ding Lili; Tan Liuxin; Liang Fei; Liu Nan; Yuan Fang; Sun Yuying; Xi Yongzhi
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

8.  Vaccination of cats with attenuated feline immunodeficiency virus proviral DNA vaccine expressing gamma interferon.

Authors:  Soumi Gupta; Christian M Leutenegger; Gregg A Dean; Jonathan D Steckbeck; Kelly Stefano Cole; Ellen E Sparger
Journal:  J Virol       Date:  2006-11-01       Impact factor: 5.103

9.  Use of genetic immunization to generate a high-level antibody against rat dicarboxylate transporter.

Authors:  Guoshuang Xu; An Liu; Xiaowei Liu
Journal:  Int Urol Nephrol       Date:  2008-08-09       Impact factor: 2.370

10.  Skin electroporation: effects on transgene expression, DNA persistence and local tissue environment.

Authors:  Anna-Karin Roos; Fredrik Eriksson; James A Timmons; Josefine Gerhardt; Ulrika Nyman; Lindvi Gudmundsdotter; Andreas Bråve; Britta Wahren; Pavel Pisa
Journal:  PLoS One       Date:  2009-09-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.